250
Participants
Start Date
January 6, 2025
Primary Completion Date
August 1, 2027
Study Completion Date
November 1, 2027
Buprenorphine
Buprenorphine in a highly effective treatment for opioid use disorder (OUD). Buprenorphine dose guidelines for OUD treatment were determined by clinical trials conducted in populations with a history of heroin use. However, fentanyl is changing the calculation of treatment, and optimal buprenorphine dosing for people who use fentanyl is unknown.
RECRUITING
Brown University, Providence
Collaborators (1)
Brown University
OTHER
Rhode Island Hospital
OTHER